Nice find EDDHC, that is a MASSIVE number. You would think that Synlait have a reasonable estimate of the growth in demand, and A2M is their major formula customer. An increase of at least 12350MT corresponds to about 13.7M 900g tins of formula. At estimate $20 NZD per tin this gives about $274M NZD formula revenue for FY16. And that is projected growth ABOVE baseline.
Formula revenue for FY15 was $41.7M. In Nov A2M indicated that formula accounted for 47% of group revenue (approx $134M of $285M total revenue forecast at that stage, lifting to $149M to $164M range in Dec update). Sunlight's forecast is a long way above these estimates. If Synlait's forecasts are right they are anticipating a HUGE further lift in formula demand in 2H16. All good news.
- Forums
- Charts
- Synlait update Dec 16 and Dec 8
Nice find EDDHC, that is a MASSIVE number. You would think that...
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.81 |
Change
-0.090(1.84%) |
Mkt cap ! $3.482B |
Open | High | Low | Value | Volume |
$4.92 | $4.95 | $4.80 | $8.716M | 1.802M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 10795 | $4.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.83 | 5662 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 10795 | 4.810 |
14 | 50515 | 4.800 |
10 | 88280 | 4.790 |
8 | 128503 | 4.780 |
4 | 31267 | 4.770 |
Price($) | Vol. | No. |
---|---|---|
4.830 | 5662 | 1 |
4.840 | 6237 | 1 |
4.850 | 50303 | 2 |
4.890 | 15000 | 2 |
4.930 | 15000 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online